openPR Logo
Press release

BathExpo Elevates Brooklyn Kitchens with Bespoke Cabinetry Solutions

05-23-2025 10:18 PM CET | Industry, Real Estate & Construction

Press release from: ABNewswire

BathExpo Elevates Brooklyn Kitchens with Bespoke Cabinetry

Brooklyn, NY - May 23, 2025 - BathExpo, a family-owned design and renovation company established in 1994, is redefining kitchen spaces across Brooklyn [https://bathexpo.us/contact-us/] and beyond with its premium custom kitchen cabinets. Known for blending elegance with functionality, BathExpo crafts tailored cabinetry that aligns with each client's unique lifestyle and aesthetic preferences.

Operating from their showroom at 750 3rd Avenue in Brooklyn, BathExpo offers a diverse range of cabinet styles, including modern, traditional, and transitional designs. Each piece is meticulously crafted using high-quality materials, ensuring durability and a refined finish that enhances any kitchen's appeal.

"Our mission has always been to transform kitchens into personalized spaces that resonate with our clients' visions," said a BathExpo representative. "With over 30 years of experience, we pride ourselves on delivering cabinetry that combines superior craftsmanship with timeless design."

Clients can initiate their kitchen transformation [https://bathexpo.us/custom-kitchen-cabinets-bathexpo/] by completing BathExpo's Custom Kitchen Cabinet Order Form, allowing the design team to understand specific requirements and preferences. The company's commitment to customer satisfaction is evident in its comprehensive service, from initial consultation to final installation.

In addition to custom cabinetry, BathExpo's affiliation with G&G Tub & Tile Reglazing and Bache Audio enables them to offer a holistic approach to home renovation, providing services like tile refinishing and high-end audio solutions.

Contact Information:

BathExpo

750 3rd Avenue, Brooklyn, NY, 11232

Phone: +1 (718) 369-9700 / +1 (718) 241-7314

Email: info@bathexpo.us

Website: https://bathexpo.us/

About BathExpo:

Since 1994, BathExpo has been a trusted name in kitchen and bathroom design, offering custom solutions that marry style with practicality. Their Brooklyn showroom showcases a wide array of products, reflecting the company's dedication to quality and innovation in home renovation.

For media inquiries, please contact:

BathExpo Public Relations

Email: info@bathexpo.us [mailto:info@bathexpo.us]

Phone: +1 (718) 369-9700

Media Contact
Company Name: BathExpo US
Contact Person: Lev
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=bathexpo-elevates-brooklyn-kitchens-with-bespoke-cabinetry-solutions]
Country: United States
Website: http://www.bathexpo.us

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BathExpo Elevates Brooklyn Kitchens with Bespoke Cabinetry Solutions here

News-ID: 4034122 • Views:

More Releases from ABNewswire

Fuchs Dystrophy Clinical Trial Outlook: 5+ Companies and 7 Emerging Therapies Reshape the Global Treatment Pipeline, Says DelveInsight
Fuchs Dystrophy Clinical Trial Outlook: 5+ Companies and 7 Emerging Therapies Re …
Fuchs Dystrophy companies include Kowa Pharmaceutical, Trefoil Therapeutics, Design Therapeutics, Emmecell, Santen Inc., Kowa Company Ltd, Adam Fedyk MD FACS, and Kowa Research Institute Inc. DelveInsight's Fuchs Dystrophy Pipeline Insight report provides an extensive clinical and commercial assessment of therapeutic candidates spanning early preclinical research to approved and marketed treatments. The study presents in-depth drug profiles detailing mechanisms of action, recent clinical trial progress, regulatory developments (including NDA activity where relevant),
Obesity Market on Track for Major Expansion by 2034, According to DelveInsight | Rhythm Pharmaceuticals, Boehringer Ingelheim, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical, Bukwang Pharm
Obesity Market on Track for Major Expansion by 2034, According to DelveInsight | …
The Key Obesity Companies in the market include - Rhythm Pharmaceuticals, Boehringer Ingelhium, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical, Bukwang Pharmaceutical, Caliway Biopharmaceutics, Yuhan, Terns Pharmaceuticals, BioRestorative Therapies, SCOHIA PHARMA, Click Therapeutics, Hanmi Pharmaceuticals, Novo Nordisk, Empros Pharma, Carmot Therapeutics, Eli Lilly and Company, and others. DelveInsight's "Obesity Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Obesity, historical and forecasted epidemiology as well as the
Diabetic Macular Edema Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Oxurion, Ocuphire Pharma, YD Life Science, Unity Biotech
Diabetic Macular Edema Pipeline 2025: Comprehensive Clinical Trials and Therapie …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Macular Edema pipeline constitutes key companies continuously working towards developing Diabetic Macular Edema treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Diabetic Macular Edema Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/diabetic-macular-edema-dme-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Diabetic Macular Edema Market. The Diabetic Macular
Chronic Lymphocytic Leukemia Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Janssen R&D, NovalGen, Genmab, Ascentage Pharma Group, Loxo
Chronic Lymphocytic Leukemia Pipeline 2025: Therapies Under Investigation, Clini …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Lymphocytic Leukemia pipeline constitutes 55+ key companies continuously working towards developing 60+ Chronic Lymphocytic Leukemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Chronic Lymphocytic Leukemia Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/chronic-lymphocytic-leukemia-cll-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Chronic Lymphocytic Leukemia Market. The

All 5 Releases